Browse By: Country ι Category ι Latest Reports ι Tag

Hepatitis Market Research Reports

Hepatitis C Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.  The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected indi
Published Date: Apr 2025
Published By: Transparency

Price: $4795
Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two mont
Published Date: Nov 2020
Published By: Transparency

Price: $4795
United States Hepatitis B Vaccine Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstrea
Published Date: Feb 2016
Published By: QYResearch

Price: $3800
Europe Hepatitis A Vaccine Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis A Vaccine market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw material
Published Date: Jan 2016
Published By: QYResearch

Price: $3600
Global Hepatitis B Vaccine Consumption 2016 Market Research Report
First, the report provides a basic overview of the Hepatitis B Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Hepatitis B Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Hepatitis B Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with infor
Published Date: Jan 2016
Published By: QYResearch

Price: $4000
Global Hepatitis A Vaccine Consumption 2016 Market Research Report
First, the report provides a basic overview of the Hepatitis A Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Hepatitis A Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Hepatitis A Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with infor
Published Date: Jan 2016
Published By: QYResearch

Price: $4000
Global Hepatitis B Vaccine Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, p
Published Date: Jan 2016
Published By: QYResearch

Price: $2800
Global Hepatitis A Vaccine Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis A Vaccine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Published Date: Jan 2016
Published By: QYResearch

Price: $2800
Hepatitis C Virus (HCV) Protease Inhibitors - Pipeline Insights, 2016
DelveInsight’s, “Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis C Virus (HCV) Protease Inhib
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis C Report is to understand the market and pipeline status of the drugs around the Hepatitis C to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis C. While the leading brands, companies a
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis B Report is to understand the market and pipeline status of the drugs around the Hepatitis B to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis B. While the leading brands, companies a
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis Report is to understand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis. While the leading brands, companies and che
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Steatohepatitis-Pipeline Insights, 2016
DelveInsight’s, “ Steatohepatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Steatohepatitis. DelveInsight’s Report also assesses the Steatohepatitis therapeutics by Mon
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2016
DelveInsight’s, “ Non-Alcoholic Steatohepatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Alcoholic Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non-Alcoholic Steatohepatitis. DelveInsight’s Report also assess
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2016
DelveInsight’s, “ Hepatitis D-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis D. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis D. DelveInsight’s Report also assesses the Hepatitis D therapeutics by Monotherapy, Combin
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis A-Pipeline Insights, 2016
DelveInsight’s, “ Hepatitis A-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis A. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis A. DelveInsight’s Report also assesses the Hepatitis A therapeutics by Monotherapy, Combin
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis C - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H2 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Dec 2015
Published By: Global Markets Direct

Price: $2000
Global NASH (Non-Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs - Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market)
The Global NASH Market is growing at a moderate rate over last five years on account of rising number of obesity among young population. NASH (non-alcoholic steatohepatitis) is a large, un-tapped market with no FDA approved therapeutics. Antioxidants, anti-diabetic medications, anti-obesity medications and antihyper Lipidemics are some of the off-label products currently used by NASH patients. 
Published Date: Dec 2015
Published By: Azoth Analytics

Price: $2000
Hepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial regist
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
United States Hepatitis Drugs Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Dec 2015
Published By: QYResearch

Price: $3800
EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024
Summary The Hepatitis B Virus (HBV) can cause both acute and chronic liver disease. HBV is typically transmitted through contact with infectious blood or bodily fluid, including vertical transmission from mother to child at birth and transmission via sexual intercourse. Risk factors of chronic hepatitis B (CHB) include unprotected sex with an infected partner, men who have sex with men (MSM), intravenous drug injection (IDU), and a previous history of a sexually transmitted disease (STD). CHB has a well-established comorbidity association with hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection, human immunodeficiency virus (HIV) infection, and alcohol abuse. The disease often starts as asymptomatic in the acute infection phase, with symptoms beginning to present 30 to
Published Date: Dec 2015
Published By: GlobalData

Price: $3995
Global Hepatitis Drugs Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Hepatitis Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Dec 2015
Published By: QYResearch

Price: $2800
Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalDatas clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoholic Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ di
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
Steatohepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalDatas clinical trial report, “Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Steatohepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clin
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
Global Hepatitis Drugs Market 2015-2019
Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections. Technavio's analysts forecast the global hepatitis drugs market to grow at a CAGR of 17.1% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global hepatitis drugs market for the period 2015-2019
Published Date: Dec 2015
Published By: Technavio

Price: $3000
Global Hepatitis A Vaccine Sales 2015 Market Research Report
The report provides a basic overview of the Hepatitis A Vaccine industry including definitions, classifications, applications and industry chain structure. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report then analyzes the global Hepatitis A Vaccine market size (volume and value), and the sales segment market is also discussed by product type, application and region. The major Hepatitis A Vaccine market (including USA, Europe, China, Japan, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and application. Then we forecast the 2016-2021
Published Date: Dec 2015
Published By: QYResearch

Price: $4000
United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report
The United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Prophylactic Hepatitis B Virus Vaccines industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prophylactic Hepatitis B Virus Vaccines market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margi
Published Date: Dec 2015
Published By: QYResearch

Price: $3800
Hepatitis D - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H2 2015’, provides an overview of the Hepatitis D’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis D, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis D and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Nov 2015
Published By: Global Markets Direct

Price: $2000
Global Hepatitis A and B Combined Vaccine Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Hepatitis A and B Combined Vaccine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Oct 2015
Published By: QYResearch

Price: $2900
Global Hepatitis A Live vaccine Freeze-dried Industry 2015 Market Research Report
The Global Hepatitis A(Live)vaccine,Freeze-dried Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Hepatitis A(Live)vaccine,Freeze-dried industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
Published Date: Oct 2015
Published By: QYResearch

Price: $2900
Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 t
Published Date: Oct 2015
Published By: Global Markets Direct

Price: $2000
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019
Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home. Technavio's analysts forecast the global viral hepatitis and retroviru
Published Date: Oct 2015
Published By: Technavio

Price: $2500
Global Human Hepatitis B Immunoglobulin Industry 2015, Trends and Forecast Report
The report firstly introduced the Human Hepatitis B Immunoglobulin basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Human Hepatitis B Immunoglobulin industry; 3.) the North American Human Hepatitis B Immunoglobulin industry; 4.) the European Human Hepatitis B Immunogl
Published Date: Oct 2015
Published By: 9Dimen Research

Price: $2850
Hepatitis Viruses - Pipeline Review 2015
Summary GlobalData's Medical Devices sector report, “Hepatitis Viruses - Pipeline Review, 2015" provides an overview of Hepatitis Viruses diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses diagnostic tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain s
Published Date: Oct 2015
Published By: GlobalData

Price: $4000
Alcoholic Hepatitis - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H2 2015’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcoholic Hepatitis and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indication
Published Date: Sep 2015
Published By: Global Markets Direct

Price: $2000
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Non-Alcoholic Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Alcoholic Steatohepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinica
Published Date: Sep 2015
Published By: GlobalData

Price: $2500
Global Hepatitis B Vaccines Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Hepatitis B Vaccines market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Sep 2015
Published By: QYResearch

Price: $2800
Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth
Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern. Incidence tends to be higher in countries with a significant number of migrants from medium and high-prevalence countries.
Published Date: Sep 2015
Published By: GBI Research

Price: $4995
Global Duck Virus Hepatitis Vaccines Industry 2015 Market Research Report
The Global Duck Virus Hepatitis Vaccines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Duck Virus Hepatitis Vaccines industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Duck Virus Hepatitis Vaccines market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading indus
Published Date: Sep 2015
Published By: QYResearch

Price: $2800
Global Hepatitis C Pipeline Drugs Industry 2015 Market Research Report
The Global Hepatitis C Pipeline Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Hepatitis C Pipeline Drugs industry.
Published Date: Sep 2015
Published By: QYResearch

Price: $2800
China Hepatitis C Pipeline Drugs Industry 2015 Market Research Report
The China Hepatitis C Pipeline Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Hepatitis C Pipeline Drugs industry.
Published Date: Sep 2015
Published By: QYResearch

Price: $3200
Japan Hepatitis C Pipeline Drugs Industry 2015 Market Research Report
The Japan Hepatitis C Pipeline Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Hepatitis C Pipeline Drugs industry.
Published Date: Sep 2015
Published By: QYResearch

Price: $3400
Europe Hepatitis C Pipeline Drugs Industry 2015 Market Research Report
The Europe Hepatitis C Pipeline Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Hepatitis C Pipeline Drugs industry.
Published Date: Sep 2015
Published By: QYResearch

Price: $3600
United States Hepatitis C Pipeline Drugs Industry 2015 Market Research Report
The United States Hepatitis C Pipeline Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Hepatitis C Pipeline Drugs industry.
Published Date: Sep 2015
Published By: QYResearch

Price: $3800
Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global
Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market. 
Published Date: Aug 2015
Published By: Renub Research

Price: $1290
Global and Chinese Hepatitis B Vaccine Industry, 2015 Market Research Report
The 'Global and Chinese Hepatitis B Vaccine Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Hepatitis B Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepatitis B Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each compa
Published Date: Jul 2015
Published By: Prof Research

Price: $2800
Hepatitis B - Pipeline Review, H1 2015
Hepatitis B - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Hepatitis B - Pipeline Review, H1 2015, provides an overview of the Hepatitis Bs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jun 2015
Published By: Global Markets Direct

Price: $2000
Hepatitis A - Pipeline Review, H1 2015
Hepatitis A - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Hepatitis A - Pipeline Review, H1 2015, provides an overview of the Hepatitis As therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis A and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jun 2015
Published By: Global Markets Direct

Price: $2000
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015"" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Alcoholic Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary re
Published Date: May 2015
Published By: GlobalData

Price: $2500
Hepatitis Partnering 2010-2015
The Hepatitis Partnering 2010-2015 report provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hepatitis partnering deals Top hepatitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hepatitis Partnering 2010-2015 provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hepatitis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hepatitis technology. These deals tend to be multicomponent, starting with co
Published Date: May 2015
Published By: Current Partnering

Price: $995
Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015"" provides data on the Autoimmune Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autoimmune Hepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autoimmune Hepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Apr 2015
Published By: GlobalData

Price: $2500
Hepatitis D - Pipeline Review, H1 2015
Global Markets Directs, Hepatitis D Pipeline Review, H1 2015, provides an overview of the Hepatitis Ds therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis D, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis D and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Apr 2015
Published By: Global Markets Direct

Price: $2000
Global Hepatitis A Vaccine Industry 2015 Market Research Report
For overview analysis, the report introduces Hepatitis A Vaccine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Hepatitis A Vaccine markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications, developments and trends of market, technology, competitive landscape, and leading suppliers’ and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and
Published Date: Apr 2015
Published By: QYResearch

Price: $2800
Global Hepatitis B Vaccine Industry 2015 Market Research Report
For overview analysis, the report introduces Hepatitis B Vaccine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Hepatitis B Vaccine markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications, developments and trends of market, technology, competitive landscape, and leading suppliers’ and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and
Published Date: Apr 2015
Published By: QYResearch

Price: $2800
Steatohepatitis-Pipeline Insights, 2015
DelveInsight’s, “ Steatohepatitis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Steatohepatitis. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Steatohepatitis. The report provides information on the therapeutic development based on the Steatohepatitis providing licensing, chemical, technology information and comparative analysis at various stages.  DelveInsight’s Report is assessing the Steatohepatitis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsight’s Reports are also highlighti
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2015
SUMMARYDelveInsights, Non-Alcoholic Steatohepatitis-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Non-Alcoholic Steatohepatitis. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Non-Alcoholic Steatohepatitis. The report provides information on the therapeutic development based on the Non-Alcoholic Steatohepatitis providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsights Report is assessing the Non-Alcoholic Steatohepatitis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsights
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2015
SUMMARYDelveInsights, Hepatitis D-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Hepatitis D. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Hepatitis D. The report provides information on the therapeutic development based on the Hepatitis D providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsights Report is assessing the Hepatitis D therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsights Reports are also highlighting the discontinued and dormant products for Hepatitis D. Dat
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Hepatitis A-Pipeline Insights, 2015
SUMMARYDelveInsights, Hepatitis A-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Hepatitis A. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Hepatitis A. The report provides information on the therapeutic development based on the Hepatitis A providing licensing, chemical, technology information and comparative analysis at various stages. DelveInsights Report is assessing the Hepatitis A therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. In addition to this, thereport has covered the key players and their financial details. DelveInsights Reports are also highlighting the discontinued and dormant products for Hepatitis A. Dat
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Hepatitis C-API Insights, 2015
DelveInsights, Hepatitis C-API Insights, 2015,report provides Hepatitis C drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Hepatitis C. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsights report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Hepatitis C drugs till 2016. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impa
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Hepatitis B-API Insights, 2015
DelveInsights, Hepatitis B-API Insights, 2015,report provides Hepatitis B drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Hepatitis B. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsights report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Hepatitis B drugs till 2016. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impa
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Hepatitis-API Insights, 2015
DelveInsights, Hepatitis-API Insights, 2015,report provides Hepatitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Hepatitis. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsights report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Hepatitis drugs till 2016. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on th
Published Date: Apr 2015
Published By: DelveInsight

Price: $1250
Alcoholic Hepatitis - Pipeline Review, H1 2015
Global Markets Directs, Alcoholic Hepatitis Pipeline Review, H1 2015, provides an overview of the Alcoholic Hepatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcoholic Hepatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Mar 2015
Published By: Global Markets Direct

Price: $2000
Steatohepatitis Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry ex
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Hepatitis C - Pipeline Review, H1 2015
Global Markets Directs, Hepatitis C - Pipeline Review, H1 2015, provides an overview of the Hepatitis Cs therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015
Global Markets Directs, Non-Alcoholic Steatohepatitis Pipeline Review, H1 2015, provides an overview of the Non-Alcoholic Steatohepatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015
GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H1, 2015"" provides data on the Alcoholic Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alcoholic Hepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alcoholic Hepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData
Published Date: Jan 2015
Published By: GlobalData

Price: $2500
Global Hepatitis B Vaccine Industry 2014 Market Research Report
2014 Global Hepatitis B Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hepatitis B Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Hepatitis B Vaccine basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, i
Published Date: Dec 2014
Published By: 9Dimen Research

Price: $2850
Hepatitis D - Pipeline Review, H2 2014
Hepatitis D - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hepatitis D - Pipeline Review, H2 2014, provides an overview of the Hepatitis Ds therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis D, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis D and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Global Human Hepatitis B Immunoglobulin Industry 2014 Market Research Report Updated

pe, and leading suppliers and countries 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.For technical data and manufacturing plants analysis, the report analyzes Human Hepatitis B Immunoglobulin leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.This report also presents product specification, manufacturing process, and product cost structure etc. Production is sep
Published Date: Dec 2014
Published By: QYResearch

Price: $2600
Hepatitis D Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Hepatitis D Global Clinical Trials Review, H2, 2014 provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Sc
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis B Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Hepatitis B Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis C Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis C - Pipeline Review, H2 2014
Hepatitis C - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hepatitis C - Pipeline Review, H2 2014, provides an overview of the Hepatitis Cs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2500
Global and Chinese Hepatitis B recombinant surface antigen Industry, 2009-2019 Market Research Report
The 'Global and Chinese Hepatitis B recombinant surface antigen Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Hepatitis B recombinant surface antigen industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepatitis B recombinant surface antigen manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity,
Published Date: Oct 2014
Published By: Prof Research

Price: $2400
Global and Chinese Hepatitis B Industry, 2009-2019 Market Research Report
The 'Global and Chinese Hepatitis B Industry, 2009-2019 Market Research Report' is a professional and in-depth study on the current state of the global Hepatitis B industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepatitis B manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2009-2014 market shares for each company. Through the statisti
Published Date: Oct 2014
Published By: Prof Research

Price: $2400
Alcoholic Hepatitis - Pipeline Review, H2 2014
Alcoholic Hepatitis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Alcoholic Hepatitis - Pipeline Review, H2 2014, provides an overview of the Alcoholic Hepatitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcoholic Hepatitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Steatohepatitis-Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days.  DelveInsights, Steatohepatitis-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Steatohepatitis. This report provides information on the therapeutic development based on the Steatohepatitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the produ
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days.  DelveInsights, Non-Alcoholic Steatohepatitis-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Non-Alcoholic Steatohepatitis. This report provides information on the therapeutic development based on the Non-Alcoholic Steatohepatitis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved i
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days. SUMMARYDelveInsights, Hepatitis D-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatitis D. This report provides information on the therapeutic development based on the Hepatitis D dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products.
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Hepatitis A-Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days. SUMMARYDelveInsights, Hepatitis A-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatitis A. This report provides information on the therapeutic development based on the Hepatitis A dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products.
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2014
The Report will be Dispatched in 3 Working Days.  DelveInsight’s,“Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatitis C Virus (HCV) Protease Inhibitors. This report provides information on the therapeutic development based on the Hepatitis C Virus (HCV) Protease Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug in
Published Date: Aug 2014
Published By: DelveInsight

Price: $1250
Hepatitis C Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
The Report will be Dispatched in 3 Working days.  DelveInsights, Hepatitis C- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclus
Published Date: Aug 2014
Published By: DelveInsight

Price: $2000
Hepatitis B Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
The Report will be Dispatched in 3 Working days.  DelveInsights, Hepatitis B- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclus
Published Date: Aug 2014
Published By: DelveInsight

Price: $2000
Hepatitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
The Report will be Dispatched in 3 Working days.  DelveInsights, Hepatitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusiv
Published Date: Aug 2014
Published By: DelveInsight

Price: $2000
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven UpdateSummaryHepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by therapeutics. Currently, drug combinations containing a direct-acting antiviral (DAA), such as Gilead's Sovaldi (sofosbuvir) or Janssen's Olysio (simeprevir), along with pegylated interferon (e.g., Roches Pegasys and Mercks PegIntron) and/or ribavirin (e.g., Roches Copegus and Mercks Rebetol) are used to treat HCV infections. Sovaldi and Olysio have largely replaced first-generation
Published Date: May 2014
Published By: GlobalData

Price: $10995
Hepatitis B - Pipeline Review, H1 2014
Hepatitis B - Pipeline Review, H1 2014SummaryGlobal Markets Directs, Hepatitis B - Pipeline Review, H1 2014, provides an overview of the Hepatitis Bs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: May 2014
Published By: Global Markets Direct

Price: $2000
Alcoholic Hepatitis - Pipeline Review, H1 2014
This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcoholic Hepatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor pres
Published Date: May 2014
Published By: Global Markets Direct

Price: $2000
Hepatitis A - Pipeline Review, H1 2014
This report provides comprehensive information on the therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis A and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and fe
Published Date: May 2014
Published By: Global Markets Direct

Price: $2000
Hepatitis Drugs Markets in China
China\'s demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: Apr 2014
Published By: Asia Market Information & Development Company

Price: $4000
Global and China Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorbent assay) Industry 2014 Market Research Report
The report firstly introduced Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorbent assay) basic information included Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorbent assay) definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorbent assay) industry policy and plan, Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorbent assay) product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Hepatitis B virus core antibody di
Published Date: Mar 2014
Published By: QYResearch

Price: $2200
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2014
This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC fi
Published Date: Mar 2014
Published By: Global Markets Direct

Price: $2000
OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update
GlobalData has released its new Opportunity Analyzer report, OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) Opportunity Analysis and Forecasts to 2017 Event-Driven Update. The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfits PPAR agonist, GFT505 and Intercept Pharmaceuticals/Dainippon Sumitomo Pharmas FXR agonist, Obeticholic Acid. These compounds will race to be the first approved therapy thus claiming first in class. Scope Overview of NASH, including epidemiology, etiology, symptoms, diagnosis, pathology and disease management.  Analysis of the current and future market competition in the global NASH therapeutics market.  Pipeline analysis: comprehensive data
Published Date: Mar 2014
Published By: GlobalData

Price: $7995
Global and China Hepatitis A and B Combined Vaccine Industry 2014 Market Research Report
The report firstly introduced Hepatitis A and B Combined Vaccine basic information included Hepatitis A and B Combined Vaccine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Hepatitis A and B Combined Vaccine industry policy and plan, Hepatitis A and B Combined Vaccine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Hepatitis A and B Combined Vaccine capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Hepatitis A and B Combined Vaccine products customers a
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Recombinant Hepatitis B Vaccine (Hansenula polymorpha) Industry 2014 Market Research Report
The report firstly introduced Recombinant Hepatitis B Vaccine(Hansenula polymorpha) basic information included Recombinant Hepatitis B Vaccine(Hansenula polymorpha) definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Recombinant Hepatitis B Vaccine(Hansenula polymorpha) industry policy and plan, Recombinant Hepatitis B Vaccine(Hansenula polymorpha) product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Recombinant Hepatitis B Vaccine(Hansenula polymorpha) capacity production cost price profit production value gross margin etc details information, at the sa
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Hepatitis C - Pipeline Review, H1 2014
Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bu
Published Date: Feb 2014
Published By: Global Markets Direct

Price: $2500
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines  Current and Future Players. The report is a vital source of uptodate information with indepth analysis on the companies in the rapidly growing Prophylactic hepatitis B virus vaccines Market. The report identifies and analyses the key companies shaping and driving the global prophylactic hepatitis B virus vaccines market. The report provides insight into the competitive prophylactic hepatitis B virus vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and inhouse analysis by GlobalDatas team of industry experts. Scope Investigation of current and future market competition for prophylactic hepatitis B virus
Published Date: Jan 2014
Published By: GlobalData

Price: $2995
Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022SummaryHepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion r
Published Date: Jan 2014
Published By: GlobalData

Price: $3495
Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rates in high-risk adults, will serve to stimulate growth in the marketplace over the forecast period. Country-specific immunization recommendations and policy implementation will be an essential metric for determining future vaccine uptake in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Canada.Comvax [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine] i
Published Date: Jan 2014
Published By: GlobalData

Price: $3495
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022SummaryHepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion ra
Published Date: Jan 2014
Published By: GlobalData

Price: $3495
Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022SummaryHepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related liver diseases. While the arrival of recombinant HBsAg vaccines has greatly reduced disease burden over the past two decades, questions surrounding vaccine uptake and effectiveness in adults, particularly in niche patient populations, still remain. GlobalData expects that the growing popularity of pediatric combination vaccines, along with the arrival of vaccines that achieve higher seroconversion rat
Published Date: Jan 2014
Published By: GlobalData

Price: $3495